Liver transplantation as part of the comprehensive management of alcohol-related liver disease
DOI:
https://doi.org/10.52784/27112330.126Abstract
The risk of relapse after liver transplantation in patients with alcoholic liver disease remains a challenge. Many post-liver transplant patients show little motivation to pursue alcohol dependence treatment, while at the same time expressing a strong belief that they have recovered from alcohol and denying the desire to drink. These responses are likely to reflect an internal drive not to consume alcohol. Post-transplant, there are patients who do not consume alcohol or only have a small occasional consumption, and this is probably what is observed by many liver transplant groups with different populations in the world. Reported rates of alcohol relapse after transplant are highly variable, ranging from 10% to 90%.
Downloads
References
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol 2018;69:154-181. https://doi.org/10.1016/j.jhep.2018.03.018.
Kitajima T, Nagai S, Segal A, Magee M, Blackburn S, Ellithorpe D, et al. Posttransplant complications predict alcohol relapse in liver transplant recipients. Liver Transpl 2020;26:379-389. https://doi.org/10.1002/lt.25712.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |















